01.07.2021 • News

Solvay Appoints Pascal Chalvon Demersay as Chief Sustainability and Government Affairs Officer

Solvay has appointed Pascal Chalvon Demersay to chief sustainability and government affairs officer, effective July 1, 2021, integrating the new responsibilities to his current role as chief sustainability officer.

Solvay said that Chalvon Demersay was the architect and an instrumental driving force behind the company’s 2030 sustainability program, Solvay One Planet.

Chalvon Demersay assumes responsibility for government affairs from Alexis Brouhns, previously head of government and public affairs, who retires after more than 16 years with Solvay.

Chalvon Demersay graduated from the Ecole Polytechnique de Paris. He started his career in 1990 as a site manager and held several management positions on different continents. In 2007, he joined Bluestar Silicones, which integrated the Solvay group’s former silicones activity, and became their CEO in 2010. In July 2015, he was appointed president of Solvay Energy Services and later became Solvay's chief sustainability officer in 2016.

Solvay has appointed Pascal Chalvon Demersay to chief sustainability and...
Solvay has appointed Pascal Chalvon Demersay to chief sustainability and government affairs officer, effective July 1, 2021. © Solvay

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read